ARTICLE | Financial News
Enlivex Therapeutics completes venture financing
February 4, 2013 8:00 AM UTC
Enlivex Therapeutics Ltd., Jerusalem, Israel Business: Transplant, Gene/Cell therapy Date completed: 1/22/13 Type: Venture financing Raised: $268,000 Investor: Hadasit Bio-Holdings Note: The financing...